Eli Lilly’s Growth Prospects Just Got a Huge Upgrade
The company’s promising Alzheimer’s drug could soon obtain approval from regulators.
Mindfully Curated
The company’s promising Alzheimer’s drug could soon obtain approval from regulators.
Can Amgen be a market-beating stock?
To receive the maximum benefit, you’ll need to reach earnings thresholds and delay benefits.
Micron’s stock has surged, but is there still room for growth?
These stocks have jumped impressively following their latest earnings reports, and they could soar higher thanks to AI.
To meet climate goals, the European Union needs to reverse the decline of its carbon-storing ecosystems like forests and peatlands
The post Despite dilution, officials say new nature law can restore EU carbon sinks appeared first on Climate Home News.
In coordination with Bitcoin Park, ARK is pleased to introduce a monthly conversation with leaders in the Bitcoin space.
Comparing these two high-profile aerospace-related companies highlights the stark difference in their operational performance.
Certain drugs commonly used to treat enlarged prostate may also decrease the risk for dementia with Lewy bodies (DLB), according to a new study. The researchers think that a specific side effect of the drugs targets a biological flaw shared by DLB and …
New research finds one copy of a protective genetic variant, APOE3 Christchurch, delayed onset of Alzheimer’s disease for 27 members of a ~6,000-person family in Colombia at high risk for early-onset Alzheimer’s in their 40s due to carrying the ‘Paisa’…